Book Review - Let Them Eat Prozac by David Healy
Category Book Reviews
Since I am acquainted with the issues of antidepressants as someone with dysthymia, I decided it might be interesting to read the "other" side of the story. To that end, I just finished Let Them Eat Prozac - The Unhealthy Relationship Between The Pharmaceutical Industry And Depression by David Healy. Interesting stuff here...
Healy is listed as a former secretary of the British Association for Psychopharmacology and has written a number of articles and books on the subject. He's also been on the prescribing end of antidepressants, so I don't see (at least on the surface) any particular conflict of interest that might color his statements and conclusions. The book is part a personal story of his experience with the drug Prozac and its parent company Lilly, as well as an expose of how pharmaceutical companies are able to distort facts and studies to present misleading results on drug testing. The main thrust of this book is how Prozac and SSRI drugs in general show a strong increase in the rate of suicidal tendencies in users during the first few weeks of use. But looking at the information from the drug companies, you'd never know it. Based on creative manipulation of statistics, the suicide rates were presented as far less than they really were. And even now that Prozac has gone off patent and is now available in its generic form of fluoxetine, he still claims that little is known about the long-term effects of the drug, and who might be held responsible if issues arise down the road.
Coming into this book, I was ready to write him off as a conspiracy nut with an axe to grind. I was given fluoxetine nearly two years ago to help me deal with chronic low-level depression, and it's been a lifesaver. I've experienced very few side effects (very minor), and it has given me a new lease on life. But after reading the book, I realize that I am pretty lucky, in that the story could have been much worse. It's nearly impossible (from what I can tell) to predict how a specific person will react on an SSRI drug. My position has been that the doctor should be watching them extremely closely over the first two to four weeks. I'd now change that to the first two to four *days*. An adverse reaction to the drug could be deadly, and for more than just the person taking the drug.
Overall, very interesting material. I would hope that reading something like this wouldn't dissuade a person from seeking treatment and trying SSRI drugs, as they can and do work well for many people. But it's valuable to understand that they don't work for everyone, and it's possible that they could make the condition even worse. Just proceed with caution...
Since I am acquainted with the issues of antidepressants as someone with dysthymia, I decided it might be interesting to read the "other" side of the story. To that end, I just finished Let Them Eat Prozac - The Unhealthy Relationship Between The Pharmaceutical Industry And Depression by David Healy. Interesting stuff here...
Healy is listed as a former secretary of the British Association for Psychopharmacology and has written a number of articles and books on the subject. He's also been on the prescribing end of antidepressants, so I don't see (at least on the surface) any particular conflict of interest that might color his statements and conclusions. The book is part a personal story of his experience with the drug Prozac and its parent company Lilly, as well as an expose of how pharmaceutical companies are able to distort facts and studies to present misleading results on drug testing. The main thrust of this book is how Prozac and SSRI drugs in general show a strong increase in the rate of suicidal tendencies in users during the first few weeks of use. But looking at the information from the drug companies, you'd never know it. Based on creative manipulation of statistics, the suicide rates were presented as far less than they really were. And even now that Prozac has gone off patent and is now available in its generic form of fluoxetine, he still claims that little is known about the long-term effects of the drug, and who might be held responsible if issues arise down the road.
Coming into this book, I was ready to write him off as a conspiracy nut with an axe to grind. I was given fluoxetine nearly two years ago to help me deal with chronic low-level depression, and it's been a lifesaver. I've experienced very few side effects (very minor), and it has given me a new lease on life. But after reading the book, I realize that I am pretty lucky, in that the story could have been much worse. It's nearly impossible (from what I can tell) to predict how a specific person will react on an SSRI drug. My position has been that the doctor should be watching them extremely closely over the first two to four weeks. I'd now change that to the first two to four *days*. An adverse reaction to the drug could be deadly, and for more than just the person taking the drug.
Overall, very interesting material. I would hope that reading something like this wouldn't dissuade a person from seeking treatment and trying SSRI drugs, as they can and do work well for many people. But it's valuable to understand that they don't work for everyone, and it's possible that they could make the condition even worse. Just proceed with caution...



Comments
between severe depression and sudden recovery. The
gap can be short, as in other ADs, anti-psychotics,
benzos, and mood stabilizers. In the interim the fatigue
and desperation which dampened the volitional energy
to commit suicide gives way to a sudden but not complete
recovery to do so -- until stabilization takes place.
Unfortunately, we no longer have hospitals in which
this kind of treatment should be monitored; particularly
during this dangerous phase.
Squiggles
Posted by Squiggles At 15:39:05 On 08/07/2005 | - Website - |
Posted by Rob McDonagh At 12:36:07 On 11/11/2004 | - Website - |
I haven't read the book so I can't comment on the content. But I can say that the FDA black box warning was very politically motivated.
Any doctor worth their salt knew of these risks before the FDA rubbed our (and patients) faces into it.
I recently went to a conference where a psychopharmacologist discussed the FDA warning and treatment of major depression and dysthymia in children and adolescence. There is some so far limited data out there but it seems to point towards a significant benefit of early medical treatment of the first episode of a mood disorder. It might keep the mood disorder from recurring over one's lifetime or worsening from dysthymia to major depression. With that info, I worry that the FDA may have made it more difficult for me to convince a family that an SSRI is the right plan of attack. A doctor friend told me today a family recently refused meds for their child b/c of the black box warning.
Just after the black box warning came out a family called worried that I would have to stop prescribing the Zoloft that has made their incredibly anxious child able to go to school without throwing up every morning. She can go to the mall with friends, go sledding with her sister and can ride the bus to school - all things she couldn't do before "better living through chemicals".
Posted by Joan At 18:31:23 On 13/11/2004 | - Website - |